Home›Search›Journal of Neuro-Oncology

Journal of Neuro-Oncology

Springer · United States · Est. 1961

ISSN1573-7373

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

days submission → published

measured · last 20 articles · accept 38d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.03

H-Indexi

163

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.993

Total Worksi

9,466

Total Citationsi

303,361

2yr Mean Citednessi

2.40

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

The Journal of Neuro-Oncology (JNO) is a multidisciplinary journal encompassing basic, translational, and clinical investigations in all research areas as they relate to cancer and the central nervous system. Provides a single forum for scientific communications among Neurologists, Neurosurgeons, Radiation oncologists, Medical oncologists, Neuropathologists, Neuroradiologists and Laboratory-based scientists conducting related research. Publishes special topical issues addressing current challenges and contemporary topics.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1961

FrequencyFifteen No. A Year, 1998-

StatusActive (last: 2026)

Total Publications9,466

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1573-7373

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

287

2019

283

7.9k

2020

261

5.2k

2021

306

4.1k

2022

311

2.9k

2023

372

2.2k

2024

472

886

2025

306

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ2

NeurologyQ2

Neurology (clinical)Q2

OncologyQ2

Subject Classification

Web of Science Categories

Clinical NeurologyOncology

Scopus Categories

Neurology (clinical)Cancer ResearchOncologyNeurology

Research Topics (OpenAlex)

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma managementNeurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsLung Cancer Research StudiesPituitary Gland Disorders and TreatmentsManagement of metastatic bone diseaseCancer, Hypoxia, and MetabolismCNS Lymphoma Diagnosis and Treatment

Frequently asked questions about Journal of Neuro-Oncology

Is Journal of Neuro-Oncology a predatory journal?

PubScope has no integrity flags on record for Journal of Neuro-Oncology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Neuro-Oncology?

Journal of Neuro-Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.40.

Is Journal of Neuro-Oncology indexed in Scopus and Web of Science?

Journal of Neuro-Oncology is indexed in Web of Science, Scopus.